Treating cancer in kidney transplant recipients
- PMID: 35945368
- DOI: 10.1038/s41585-022-00643-9
Treating cancer in kidney transplant recipients
Comment on
-
Immune checkpoint inhibitors in kidney transplant recipients: a multicentre, single-arm, phase 1 study.Lancet Oncol. 2022 Aug;23(8):1078-1086. doi: 10.1016/S1470-2045(22)00368-0. Epub 2022 Jul 6. Lancet Oncol. 2022. PMID: 35809595 Clinical Trial.
References
Original article
-
- Carroll, R. P. et al. Immune checkpoint inhibitors in kidney transplant recipients: a multicentre, single-arm, phase 1 study. Lancet Oncol. https://doi.org/10.1016/S1470-2045(22)00368-0 (2022) - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
